Loading...
 

Volume 34, Issue 4, December 2023



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(3):327-31
Analysis of the Economic-Financial Efficiency of Gout Treatment in Elderly Patients with Comorbidities in the Republic of Moldova
Authors Information

1Department of Internal Medicine, Rheumatology and Nephrology, Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu, Chișinău, Moldova

2 Rheumatology Laboratory, Timofei Mosneaga Republican Clinical Hospital, Chișinău, Chișinău, Moldova

3Faculty of Dentistry, Department 5 - Internal Medicine (Cardiology, Gastroenterology, Hepatology, Rheumatology, Geriatrics), Family Medicine, Occupational Medicine, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucuresti, Romania

4Department of Social Medicine and Management “Nicolae Testemitanu”, Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu, Chișinău, Moldova

5Information Laboratory, Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu, Chișinău, Moldova

References
  1. Rai SK, Burns LC, De Vera MA, Haji A, Giustini D, Choi HK. The economic burden of gout: a systematic review. Semin Arthritis Rheum 2015;45:75-80.
  2. Singh JA. The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout. Arthritis Res Ther 2014;16:R132.
  3. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002;29:2403-6.
  4. Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol 2006;18:199-203.
  5. Brook RA, Kleinman NL, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006;22:1381-9.
  6. Wertheimer A, Morlock R, Becker MA. A revised estimate of the burden of illness of gout. Curr Ther Res Clin Exp 2013;75:1-4.
  7. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012;64:1431-46.
  8. Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift. Postgrad Med 2016;128:34-40.
  9. Juraschek SP, Kovell LC, Miller ER III, Gelber AC. Gout, urate-lowering therapy, and uric acid levels among adults in the United States. Arthritis Care Res (Hoboken) 2015;67:588-92.
  10. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011;63:102-10.
  11. Edwards NL, Sundy JS, Forsythe A, Blume S, Pan F, Becker MA. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ 2011;14:10-15.
  12. Wu EQ, Forsythe A, Guerin A, Yu AP, Latremouille-Viau D, Tsaneva M. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy. Am J Ther 2012;19:e157-e166.
  13. Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009;18:415-22.
  14. DiBonaventura MD, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W. Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ 2010;13:709-18.
  15. Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J Occup Environ Med 2011;53:1025-9.
  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
  17. Reumatologie și Nefrologie. Sub redacţia Liliana Groppa, Chişinău, 2018.
  18. Rotaru L, Groppa L, Sârbu O. Osteoporosis in patients with gout. In: Abstracts of the European Congress on Osteoporosis and Osteoarthritis (ESCEO14-IOF), 2th-5th April 2014, Seville, Spain. Osteoporosis International with other metabolic bone diseases 2014, Vol. 25 supplement 2, p. 129.
  19. Rotaru L, Groppa L, Cepoi-Bulgac D, Sârbu O. Le syndrome métabolique chez les patients ne souffrant de goutte. In: Rev Rhum Ed Fr. 2016;83 (Suppl 1): A192-A193.
  20. Rotaru L, Groppa L, Sârbu O, Agachi S. Rehabilitation of pacients with gout. In: Abstracts of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO), 14–17 April 2016, Malaga, Spain. Osteoporosis International with other metabolic bone diseases 2016, Vol. 27 supplement 1, p. 827.